Sabra Health Care REIT Inc. (NASDAQ:SBRA) went down by -1.55% from its latest closing price compared to the recent 1-year high of $19.01. The company’s stock price has collected -2.51% of loss in the last five trading sessions. Press Release reported on 11/04/21 that Sabra Health Care REIT, Inc. to Attend JMP Securities Financial Services and Real Estate Conference
Is It Worth Investing in Sabra Health Care REIT Inc. (NASDAQ :SBRA) Right Now?
Plus, the 36-month beta value for SBRA is at 1.44. Opinions of the stock are interesting as 8 analysts out of 14 who provided ratings for Sabra Health Care REIT Inc. declared the stock was a “buy,” while 1 rated the stock as “overweight,” 4 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $17.71, which is $4.03 above the current price. SBRA currently public float of 213.15M and currently shorts hold a 2.18% ratio of that float. Today, the average trading volume of SBRA was 2.26M shares.
SBRA’s Market Performance
SBRA stocks went down by -2.51% for the week, with a monthly drop of -5.66% and a quarterly performance of -12.94%, while its annual performance rate touched -15.98%. The volatility ratio for the week stands at 1.99% while the volatility levels for the past 30 days are set at 2.86% for Sabra Health Care REIT Inc.. The simple moving average for the period of the last 20 days is -4.17% for SBRA stocks with a simple moving average of -17.46% for the last 200 days.
Analysts’ Opinion of SBRA
Many brokerage firms have already submitted their reports for SBRA stocks, with Robert W. Baird repeating the rating for SBRA by listing it as a “Outperform.” The predicted price for SBRA in the upcoming period, according to Robert W. Baird is $18 based on the research report published on October 08th of the current year 2021.
Truist, on the other hand, stated in their research note that they expect to see SBRA reach a price target of $18. The rating they have provided for SBRA stocks is “Buy” according to the report published on September 30th, 2021.
Mizuho gave a rating of “Neutral” to SBRA, setting the target price at $18 in the report published on July 14th of the current year.
SBRA Trading at -6.28% from the 50-Day Moving Average
After a stumble in the market that brought SBRA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -26.43% of loss for the given period.
Volatility was left at 2.86%, however, over the last 30 days, the volatility rate increased by 1.99%, as shares sank -5.09% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -11.06% lower at present.
During the last 5 trading sessions, SBRA fell by -2.51%, which changed the moving average for the period of 200-days by -22.36% in comparison to the 20-day moving average, which settled at $14.56. In addition, Sabra Health Care REIT Inc. saw -19.46% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at SBRA starting from Cusack Catherine, who purchase 2,000 shares at the price of $17.19 back on May 13. After this action, Cusack Catherine now owns 5,891 shares of Sabra Health Care REIT Inc., valued at $34,380 using the latest closing price.
FOSTER MICHAEL J, the Director of Sabra Health Care REIT Inc., sale 6,000 shares at $17.43 during a trade that took place back on Mar 04, which means that FOSTER MICHAEL J is holding 39,667 shares at $104,610 based on the most recent closing price.
Stock Fundamentals for SBRA
Current profitability levels for the company are sitting at:
- +27.57 for the present operating margin
- +38.10 for the gross margin
The net margin for Sabra Health Care REIT Inc. stands at +24.05. The total capital return value is set at 2.76, while invested capital returns managed to touch 2.41. Equity return is now at value -1.50, with -0.90 for asset returns.
Based on Sabra Health Care REIT Inc. (SBRA), the company’s capital structure generated 71.28 points at debt to equity in total, while total debt to capital is 41.62. Total debt to assets is 40.60, with long-term debt to equity ratio resting at 70.74. Finally, the long-term debt to capital ratio is 41.30.
When we switch over and look at the enterprise to sales, we see a ratio of 9.39, with the company’s debt to enterprise value settled at 0.41.